Last updated: 11/07/2018 18:19:30
A study to investigate the interaction of naratriptan and dihydroergotamine in healthy volunteers.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A study to investigate the interaction of naratriptan and dihydroergotamine in healthy volunteers.
Trial description: A study to investigate the interaction of naratriptan and dihydroergotamine in healthy volunteers.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Abstract: A study to investigate the potential interaction of naratriptan and dihydroergotamine. Kempsford, R D, Nicholls, B, Lam, R, and Wintermute, S 8th Congress of the International Headache Society 6/10/1997 Amsterdam, Netherlands
Abstract: A study to investigate the potential interaction of naratriptan and dihydroergotamine. Kempsford, RD MD, Nicholls, B MD, Lam, R MD, and Wintermute, S Md 39th Annual Scientific Meeting of the American Association for the Study of Headache 6/22/1997 New York, New York
Abstract; no additional information beyond what was provided in the label. Kempsford RD, Cephalalgia 1997;17(3):416.
Medical condition
Migraine Disorders
Product
naratriptan
Collaborators
Not applicable
Study date(s)
July 1996 to July 1996
Type
Not applicable
Phase
1
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1996-13-07
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website